Immunization: vital progress, unfinished agenda
Vaccination against infectious diseases has changed the future of the human species,
saving millions of lives every year, both children and adults, and providing major benefits to …
saving millions of lives every year, both children and adults, and providing major benefits to …
Valuing vaccination
T Bärnighausen, DE Bloom… - Proceedings of the …, 2014 - National Acad Sciences
Vaccination has led to remarkable health gains over the last century. However, large
coverage gaps remain, which will require significant financial resources and political will to …
coverage gaps remain, which will require significant financial resources and political will to …
Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic
We present evidence for multiple independent origins of recombinant SARS-CoV-2 viruses
sampled from late 2020 and early 2021 in the United Kingdom. Their genomes carry single …
sampled from late 2020 and early 2021 in the United Kingdom. Their genomes carry single …
[HTML][HTML] Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance …
Background Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and
14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up …
14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up …
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis
National action plans enumerate many interventions as potential strategies to reduce the
burden of bacterial antimicrobial resistance (AMR). However, knowledge of the benefits …
burden of bacterial antimicrobial resistance (AMR). However, knowledge of the benefits …
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study
GA Mackenzie, PC Hill, DJ Jeffries… - The Lancet infectious …, 2016 - thelancet.com
Background Little information is available about the effect of pneumococcal conjugate
vaccines (PCVs) in low-income countries. We measured the effect of these vaccines on …
vaccines (PCVs) in low-income countries. We measured the effect of these vaccines on …
Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent …
P Naucler, I Galanis, E Morfeldt… - Clinical Infectious …, 2017 - academic.oup.com
Background Pneumococccal conjugated pneumococcal vaccine (PCV10) and
pneumococcal conjugate vaccine 13 (PCV13), are used in childhood immunization …
pneumococcal conjugate vaccine 13 (PCV13), are used in childhood immunization …
Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease—United States, 2009–2015
HM Soeters, A Blain, T Pondo, B Doman… - Clinical Infectious …, 2018 - academic.oup.com
Abstract Background Following Haemophilus influenzae serotype b (Hib) conjugate vaccine
introduction in the 1980s, Hib disease in young children dramatically decreased, and …
introduction in the 1980s, Hib disease in young children dramatically decreased, and …
Streptococcus pneumoniae serotype 19A: worldwide epidemiology
R Isturiz, HL Sings, B Hilton, A Arguedas… - Expert review of …, 2017 - Taylor & Francis
Introduction: Streptococcus pneumoniae causes mucosal and invasive diseases with high
morbidity and mortality. Introduction of the 7-valent pneumococcal conjugate vaccine …
morbidity and mortality. Introduction of the 7-valent pneumococcal conjugate vaccine …
Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3+ 0 schedule, within the first year of life among children younger than 5 …
Summary Background Pneumococcal conjugate vaccines (PCVs) induce serotype-specific
IgG antibodies, effectively reducing vaccine-serotype carriage and invasive pneumococcal …
IgG antibodies, effectively reducing vaccine-serotype carriage and invasive pneumococcal …